Indications
Therapeutic Asset Ratings
5,099 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Capecitabine
Breast Disorder
University of Southern California
P3
B
(61)
Capecitabine
Chemotherapy-Induced Toxicity
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
P3
B
(61)
Capecitabine
Colonic Neoplasm
First Affiliated Hospital of Guangxi Medical University
P3
B
(61)
Capecitabine
Gastroesophageal Adenocarcinoma
Shanghai Zhongshan Hospital
P3
B
(61)
Capivasertib
Breast Cancer
Maryam Lustberg
P3
B
(61)
Capivasertib
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.
P3
B
(61)
Capivasertib
Prostate Cancer
VA Office of Research and Development
P3
B
(61)
Carboplatin
Lung Carcinoma
SystImmune Inc.
P3
B
(61)
Carboplatin
Radiation Injury
Sun Yat-sen University
P3
B
(61)
Carisbamate
Lennox-Gastaut Syndrome
SK Life Science, Inc.
P3
B
(61)
Celecoxib
Breast Cancer
Cairo University
P3
B
(61)
Cetuximab
Colon Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
P3
B
(61)
Cetuximab
Head And Neck Squamous Cell Carcinoma
Fate Therapeutics
P3
B
(61)
Cetuximab
Lung Cancer
Merck Sharp & Dohme LLC
P3
B
(61)
Cetuximab
Metastasis From Malignant Tumor Of Colon
Shanghai 6th People's Hospital
P3
B
(61)
Cis-Diamminedichloroplatinum Ii
Lung Neoplasm
Nanfang Hospital, Southern Medical University
P3
B
(61)
Cis-Diamminedichloroplatinum Ii
Prostate Cancer
The First Affiliated Hospital of Xiamen University
P3
B
(61)
Clemizole
Dravet Syndrome
Epygenix
P3
B
(61)
Clofarabine
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
B
(61)
Colchicinum
Atherosclerosis
University College Dublin
P3
B
(61)
Crisantaspase
Acute Myeloid Leukemia
Joanna Yi
P3
B
(61)
Crizotinib
Lung Cancer
Sun Yat-sen University
P3
B
(61)
Cyclophosphamide
Breast Carcinoma In Situ
Roswell Park Cancer Institute
P3
B
(61)
Cyclophosphamide
Cervical Cancer
Merck Sharp & Dohme LLC
P3
B
(61)
Cyclophosphamide
Esophageal Cancer
Sutro Biopharma, Inc.
P3
B
(61)
Showing 2001 to 2025 of 5,099 assets
Previous
Page 81 of 204
Next